ArticleJapanese journal of clinical oncology2025

Safety and effectiveness of tepotinib in patients with unresectable, advanced or recurrent non-small cell lung cancer with METex14 skipping alterations: post-marketing surveillance in Japan.

Terufumi Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.